Home PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
Article Open Access

PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway

  • Feng Chen EMAIL logo , Xiaoxiao Cai and Ying Yu
Published/Copyright: November 4, 2024

Abstract

Fibrosis is the primary cause of retinal detachment and visual decline. Here, we investigated the role of Prohibitin 2 (PHB2) in modulating fibrosis in ARPE-19 cells stimulated by transforming growth factor (TGF)-β2. The proliferation, migration, and apoptosis of ARPE-19 cells were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, wound healing, and flow cytometry assays, and levels of fibrosis-associated and pathway-related proteins were determined by performing western blotting. To examine the mechanisms underlying ARPE-19 cell fibrosis, we performed RNA sequencing, protein–protein interaction network, and enrichment analyses. We detected increases in the expression of the fibrosis-related proteins fibronectin and collagen I in response to TGF-β2 treatment, whereas the expression of PHB2 was downregulated. PHB2 overexpression suppressed the proliferation and migration of TGF-β2-stimulated ARPE-19 cells, promoted apoptosis, and inhibited fibrosis and Smad and non-Smad pathways. PHB2 overexpression inhibited the advanced glycation end-product (AGE)–receptor of advanced glycation end-product (RAGE) pathway activated by TGF-β2 treatment, which contributed to enhancing the effects of PHB2 on cellular processes, fibrosis, and Smad and non-Smad pathways. Conversely, exogenous application of AGE counteracted the effects of PHB2 overexpression. We conclude that by suppressing the AGE–RAGE pathway, PHB2 exerts an inhibitory effect on TGF-β2-induced fibrosis in ARPE-19 cells.

1 Introduction

The retinal pigment epithelium (RPE) is a single layer of pigment cells lying between the neuroretina and choroid that contributes to maintaining visual function [1]. Dedifferentiation, migration, and growth of RPE cells can eventually lead to the development of myofibroblasts, thereby inducing proliferative vitreoretinopathy [2]. Subretinal fibrosis inevitably leads to severe and irreversible visual impairment [3,4], and currently, patients with subretinal fibrosis seldom benefit from common anti-vascular endothelial growth factor therapy [5]. Consequently, there is a pressing need to identify effective treatments for this fibrosis.

Transforming growth factor-beta (TGF-β), which has been established to regulate immune responses and inflammatory processes, is considered one of the major factors contributing to the development of fibrosis [6,7], and Smad- and non-Smad-dependent pathways have been identified as the major transmitters of TGF-β signaling [8]. These pathways contribute to the regulation of cell proliferation, thereby playing an intrinsic basal role in the fibrotic response and development of RPE cells [9,10]. The Smad-dependent pathways mainly involve Smad2 and Smad3 that form trimers with Smad4 and undergo nuclear translocation to regulate the expression of related genes, whereas non-Smad-dependent pathways include the Akt, PI3K, and MAPK (e.g., JNK, p38MAPK, and ERK1/2) signaling pathways [11,12]. However, the specific mechanisms whereby TGF-β induces fibrosis in RPE cells have yet to be sufficiently determined.

Prohibitin (PHB) 1 and PHB2 are two PHB subunits found mainly within the inner mitochondrial membrane, nucleus, cytoplasm, plasma membrane, endoplasmic reticulum, and macrophage phagosomes [13,14], wherein they play roles in the regulation of aging and the development of proliferative, degenerative, and metabolic diseases [15,16,17,18]. PHB2 has been identified as an autophagy receptor expressed on the inner mitochondrial membrane that induces mitochondrial autophagy following the rupture of the outer mitochondrial membrane [19]. In diabetic nephropathy, mitochondrial autophagy in tubular epithelial cells of the kidney contributes to reductions in damaged mitochondria and interstitial fibrosis [20]. Additionally, the overexpression of PHB has been demonstrated to inhibit apoptosis and the production of reactive oxygen species, thereby suppressing renal tubule atrophy and fibrosis following renal transplantation [21]. Furthermore, inhibition of mitochondrial autophagy has been found to ameliorate myocardial fibrosis in rats with myocardial infarction, whereas downregulation of PHB2 has been shown to inhibit the fibrosis of cardiac fibroblasts [22,23]. To date, however, the role of PHB2 in subretinal fibrosis has yet to be determined.

Advanced glycation end-products (AGEs) are heterogeneous toxic compounds produced when proteins are exposed to reducing sugars [24]. Endogenous formation of AGEs can promote oxidative stress and protein modification, thereby contributing to the regulation of inflammatory gene expression and the subsequent enhanced production of inflammatory cytokines [25]. Additionally, the interaction between AGEs and their respective receptors (RAGEs) has been demonstrated to promote the dysregulation of cell signaling and inflammatory responses [26]. Moreover, it has been established that the AGE–RAGE pathway plays a prominent role in the development of fibrosis, including that of cardiac, renal, hepatic, and pulmonary tissues [27,28,29], and it has also been reported that AGEs are pathological factors involved in the occurrence and development of diabetic retinopathy and have accordingly been identified as therapeutic targets for blocking the progression of this disease [30]. However, although AGE synthesis has been shown to promote biochemical impairment in retinal tissues, mediated by both RAGE-dependent and -independent receptors [31,32], the role of the AGE–RAGE pathway in subretinal fibrosis has yet to be established.

In this study, we sought to determine the potential regulatory mechanisms underlying the development of subretinal fibrosis and thereby provide a theoretical basis and therapeutic targets for the treatment of this disease. To this end, we used TGF-β to induce fibrosis in RPE cells, and by overexpressing PHB2, we investigated the role of this protein in RPE cell fibrosis. In addition, to elucidate the mechanisms whereby PHB2 contributes to the development of fibrosis, we performed RNA sequencing.

2 Methods

2.1 Cell culture and transfection

Human RPE cells (ARPE-19: iCell-h020; iCell Bioscience Inc, Shanghai, China) were incubated in DMEM/F12 medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (Gibco, Grand Island) and 1% Penicillin/Streptomycin Solution (Invitrogen, Carlsbad, CA, USA) in a 5% CO2 incubator at 37°C. After reaching 80% confluence, the cells were incubated with 10 ng/mL recombinant human TGF-β2 (R&D Systems, Minneapolis, MN, USA). PHB2-overexpressing lentiviral and control vectors were constructed, and Lipofectamine 3000 Reagent (Thermo Fisher Scientific) was used for cell transfection.

2.2 RNA-sequencing

RNA was extracted from ARPE-19 cells using a MasterPure Complete DNA and RNA Purification Kit (MC85200; Epicenter, Madison, WI, USA), and the RNA thus obtained was analyzed using an Agilent 2100 Bioanalyzer (Santa Clara, California, USA). RNA library construction was performed using an Illumina Tru Seq RNA library construction kit to convert RNA to cDNA and subsequently attach sequencing adapters. The RNA was sequenced using the Illumina HiSeq X Ten sequencing platform.

2.3 Analysis of differentially expressed genes

The criteria for defining differential gene expression were as follows: differential expression multiple |log2FoldChange| > 1 and significant P-value <0.05. Two-way clustering analysis was performed using the pheatmap software package in R for the identified differential expressed genes (DEGs). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using DAVID (https://david.ncifcrf.gov/).

2.4 Cell treatment

Induction of fibrosis using TGF-β2 was performed as described in Section 2.1. To assess the effects of the AGE–RAGE pathway on fibrosis in RGE cells, we added 20 μg/mL of the AGE inhibitor ALT-711 (MedChemExpress, New Jersey, USA) to cell culture medium containing isopycnic DMSO and maintained for 24 h. AGE-modified bovine serum albumin was prepared by incubation with bovine serum albumin and d-glucose for 8 weeks and was subsequently purified, as previously described [33], and to investigate the regulatory effects of PHB2 on the AGE–RAGE pathway, cells were treated with 100 μg/mL AGE.

2.5 Determination of cell proliferation

To assess cell proliferation, we performed the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) assay. ARPE-19 cells were initially seeded in the wells of 96-well plates (1 × 104/well) and incubated in a 5% CO2 incubator at 37℃ for 24 h. Subsequently, 20 μL of 0.5 mg/mL MTT reagent (Solarbio, Beijing, Shanghai) was added to the cells followed by incubation at 37°C for 2 h. After subsequently removing the MTT reagent, DMSO (150 mL) was also added and the cells were incubated for 10 min, after which the absorbance at 490 nm was recorded using a microplate reader.

2.6 Wound healing assay

The ARPE-19 cells were seeded into the six-well plates (5 × 105/well) and cultured until reaching 80% confluence, and which point, a “wound” was created in the cell layer using a pipette tip. After washing with PBS, the cells were then seeded in a serum-free medium and incubated at 37°C for 24 h. The wound was subsequently observed under a microscope at 0 and 24 h, and cell migration capacity was analyzed using ImageJ software.

2.7 Apoptosis assessment

Apoptosis was evaluated by flow cytometry using an Annexin V-FITC Apoptosis Assay Kit (Vazyme, Nanjing, China). ARPE-19 cells were resuspended in 1× binding buffer and mixed with Annexin V-FITC and PI staining solutions. Fluorescence intensity was measured by flow cytometry and analyzed using FlowJo software.

2.8 Western blotting

Proteins were extracted from ARPE-19 cells using RIPA lysis buffer (Biosharp, Beijing, China), the concentrations of which were determined using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). The isolated proteins were separated on 10% sodium dodecyl sulfate-polyacrylamide gels and transferred onto polyvinylidene fluoride membranes. Having initially blocked the membranes with 5% skim milk, they were incubated overnight at 4°C with the following selected primary antibodies: anti-Fibronectin (1:2,000; Abcam, Cambridge, MA, USA), anti-collagen I (1:2,000; Abcam), anti-PHB2 (1:2,000; Abcam), anti-Smad (1:2,000; Abcam), anti-E2F11 (1:2,000; Abcam), anti-PI3K (1:2,000; Abcam), anti-AKT (1:2,000; Abcam), anti-MEK1/2 (1:2,000; Abcam), anti-AGE (1:2,000; Abcam), anti-RAGE (1:2,000; Abcam), and anti-β-actin (1:1,000, Abcam). In the following day, the membranes were incubated with anti-rabbit IgG secondary antibody (1:5,000; Abcam) for 1 h at room temperature. Bands were scanned using a Tanon 5200 automatic chemiluminescence image analysis system (Shanghai, China), with ECL luminescent solution being used for color development.

2.9 Statistical analysis

All data, expressed as the mean ± standard deviation, were statistically analyzed using GraphPad Prism 7.0. Comparisons between two groups were analyzed using t-tests and a one-way analysis of variance was used for the analysis of multi-group comparisons, followed by Tukey’s multiple comparison test. Statistical significance was set at P < 0.05.

3 Results

3.1 TGF-β2 induces fibrosis and PHB2 downregulation in ARPE-19 cells

Following treatment with TGF-β2 for 24 and 48 h, we detected significantly higher levels of fibronectin and collagen I expression, whereas significant reduction was detected in the levels of PHB2 (Figure 1).

Figure 1 
                  PHB2 was downregulated in TGF-β2-induced ARPE-19 cells. Western blotting detected the expressions of fibronectin, collagen I, and PHB2 in TGF-β2-induced ARPE-19 cells. *P < 0.05 compared with 0 h. **P < 0.01 compared with 0 h.
Figure 1

PHB2 was downregulated in TGF-β2-induced ARPE-19 cells. Western blotting detected the expressions of fibronectin, collagen I, and PHB2 in TGF-β2-induced ARPE-19 cells. *P < 0.05 compared with 0 h. **P < 0.01 compared with 0 h.

3.2 PHB2 overexpression inhibits proliferation and migration and promotes apoptosis of TGF-β2-induced ARPE-19 cells

The transfection efficiency was verified by Western blotting, which indicated that PHB2 expression in the TGF-β2 group was considerably lower than that in the control group. Whereas we detected no substantial difference between the TGF-β2 + vector and TGF-β2 groups with respect to PHB2 expression, significantly higher levels of PHB2 expression were observed in the TGF-β2 + PHB2 group (Figure 2a).

Figure 2 
                  Overexpression of PHB2 inhibited cell proliferation, migration, and promoted cell apoptosis of TGF-β2-induced ARPE-19 cells. (a) Western blotting detected the expression of PHB2. (b) Cell proliferation was detected by MTT assay. (c) Cell migration was detected by wound-healing assay. (d) Flow cytometry was used to detect apoptosis. **P < 0.01 compared with the control group. ##
                     P < 0.01 compared with the TGF-β2 + vector group.
Figure 2

Overexpression of PHB2 inhibited cell proliferation, migration, and promoted cell apoptosis of TGF-β2-induced ARPE-19 cells. (a) Western blotting detected the expression of PHB2. (b) Cell proliferation was detected by MTT assay. (c) Cell migration was detected by wound-healing assay. (d) Flow cytometry was used to detect apoptosis. **P < 0.01 compared with the control group. ## P < 0.01 compared with the TGF-β2 + vector group.

Compared with the control group, a significant promotion of ARPE-19 cell proliferation and migration was detected in the TGF-β2 + vector and TGF-β2 + PHB2 groups. Conversely, compared with the TGF-β2 + vector group, cell proliferation and migration were found to be significantly inhibited in the TGF-β2 + PHB2 group (Figure 2b and c). The results of flow cytometry revealed notably reduced rates of apoptosis in the TGF-β2 + vector and TGF-β2 + PHB2 groups compared with the control group, whereas the levels of apoptosis in the TGF-β2 + PHB2 group were considerably higher than those in the TGF-β2 + vector group (Figure 2d).

3.3 PHB2 overexpression inhibits Smad- and non-Smad-dependent pathways

Given that Smad- and non-Smad-dependent pathways have been established to mediate TGF-β signal transmission, we examined the expression of phosphorylated Smad (p-Smad4 and E2F1) and non-Smad (p-PI3K, p-AKT, and p-MEK1/2)-dependent pathway proteins. Compared with the control group, we accordingly detected significantly higher levels of p-Smad4 and E2F1 expression in the TGF-β2 + vector group, whereas compared with the TGF-β2 + vector group, there were significant reductions in the expression of p-Smad4 and E2F1 in the TGF-β2 + PHB2 group (Figure 3a). Moreover, compared with the control group, significantly higher levels of p-PI3K, p-AKT, and p-MEK1/2 were detected in the TGF-β2 + vector group. However, compared with the TGF-β2 + vector group, there were significant reductions in the expression of p-PI3K, p-AKT, and p-MEK1/2 in the TGF-β2 + PHB2 group (Figure 3b).

Figure 3 
                  Overexpression of PHB2 regulated Smad-dependent and non-Smad-dependent pathways. (a) Western blotting detected the expressions of Smad 4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the control group. ##
                     P < 0.01 compared with the TGF-β2 + vector group.
Figure 3

Overexpression of PHB2 regulated Smad-dependent and non-Smad-dependent pathways. (a) Western blotting detected the expressions of Smad 4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the control group. ## P < 0.01 compared with the TGF-β2 + vector group.

3.4 DEG selection

A total of 2387 DEGs were selected from the TGF-β2 + vector and TGF-β2 + PHB2 groups, among which 2,164 and 223 genes were significantly up- and downregulated, respectively (Figure S1a). The cluster map presented in Figure S1b showed the bidirectional clustering of both groups of DEGs.

3.5 GO and KEGG enrichment analyses

GO functional analysis revealed that in the cell component category, terms associated with “organelles” and “nuclei” were significantly enriched with DEGs, whereas in the biological processes category, the terms “nucleic acid metabolism” and “heterocyclic metabolism” were significantly enriched. Furthermore, “nucleic acid binding” and “heterocyclic compound binding” were identified as significantly enriched terms in the molecular functions category (Figure S2a). In addition, KEGG pathway analysis revealed that DEGs were mainly concentrated in the TGF-β, AGE–RAGE, TNF, P53, Il-17, and PI3K–Akt signaling pathways (Figure S2b).

3.6 TGF-β2 activates the AGE–RAGE pathway in ARPE-19 cells

As a target pathway in the present study, we selected the AGE–RAGE pathway. Compared with the control group, the expression of PHB2 in the TGF-β2 group was significantly lower, whereas the levels of AGE and RAGE were considerably higher. Compared with the TGF-β2 group, we detected a significant increase in the expression of PHB2 in the TGF-β2 + PHB2 group, whereas there were significant reductions in the levels of AGE and RAGE. However, we detected no significant difference between the TGF-β2 + ALT711 and TGF-β2 groups with respect to the expression of PHB2, whereas the levels of AGE and RAGE were significantly reduced in the former. Furthermore, there were no significant differences between the TGF-β2 + PHB2 + ALT711 and TGF-β2 + PHB2 groups regarding the expression of PHB2, whereas the levels of AGE and RAGE were significantly lower in the former (Figure 4).

Figure 4 
                  TGF-β2 induced AGE–RAGE pathway activation in ARPE-19 cells. Western blotting detected the expressions of PHB2, AGE, and RAGE. **P < 0.01 compared with the control group. ##
                     P < 0.01 compared with the TGF-β2 group. $$
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 4

TGF-β2 induced AGE–RAGE pathway activation in ARPE-19 cells. Western blotting detected the expressions of PHB2, AGE, and RAGE. **P < 0.01 compared with the control group. ## P < 0.01 compared with the TGF-β2 group. $$ P < 0.01 compared with the TGF-β2 + PHB2 group.

3.7 PHB2 inhibits fibrosis via suppression of the AGE–RAGE pathway

Compared with those in the TGF-β2 + vector group, we detected considerably lower levels of AGE, RAGE, collagen I, and fibronectin expression in the TGF-β2 + PHB2 group. In contrast, the expression of AGE, RAGE, and fibrosis-related proteins (fibronectin and collagen I) increased significantly in response to AGE treatment (Figure 5).

Figure 5 
                  PHB2 inhibited the expression of fibrosis-related proteins fibronectin and collagen I via the AGE–RAGE signaling pathway. Western blotting detected the expressions of PHB2, AGE, RAGE, fibronectin, and collagen I. **P < 0.01 compared with the TGF-β2 + vector group. ##
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 5

PHB2 inhibited the expression of fibrosis-related proteins fibronectin and collagen I via the AGE–RAGE signaling pathway. Western blotting detected the expressions of PHB2, AGE, RAGE, fibronectin, and collagen I. **P < 0.01 compared with the TGF-β2 + vector group. ## P < 0.01 compared with the TGF-β2 + PHB2 group.

3.8 PHB2 inhibits the proliferation and migration of ARPE-19 cells but promotes apoptosis by suppressing the AGE–RAGE pathway

Compared to the control group, we observed that the proliferation and migration of ARPE-19 cells were apparently promoted in the TGF-β2 group. However, compared with the TGF-β2 group, cell proliferation and migration in the TGF-β2 + PHB2 and TGF-β2 + ALT711 groups were significantly inhibited. Furthermore, compared with the TGF-β2 + PHB2 group, we detected a significant suppression of cell proliferation and migration in the TGF-β2 + PHB2 + ALT711 group (Figure 6a and b). Flow cytometry revealed that compared with that in the control group, there was a significant reduction in the rate of cellular apoptosis in the TGF-β2 group. However, compared with the TGF-β2 group, we detected significantly higher rates of apoptosis in the TGF-β2 + PHB2 and TGF-β2 + ALT711 groups, and compared with that in the TGF-β2 + PHB2 group, significantly higher rates of apoptosis were detected in the TGF-β2 + PHB2 + ALT711 group (Figure 6c).

Figure 6 
                  AGE–RAGE pathway promoted the proliferation and migration and inhibited cell apoptosis of TGF-β2-induced ARPE-19 cells. (a) MTT assay detected cell proliferation. (b) Cell migration was detected by wound-healing assay; (c) Apoptosis was detected by flow cytometry. **P < 0.01 compared with the control group. ##
                     P < 0.01 compared with the TGF-β2 group. $$
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 6

AGE–RAGE pathway promoted the proliferation and migration and inhibited cell apoptosis of TGF-β2-induced ARPE-19 cells. (a) MTT assay detected cell proliferation. (b) Cell migration was detected by wound-healing assay; (c) Apoptosis was detected by flow cytometry. **P < 0.01 compared with the control group. ## P < 0.01 compared with the TGF-β2 group. $$ P < 0.01 compared with the TGF-β2 + PHB2 group.

Compared to the TGF-β2 + Vector group, cell proliferation and migration were significantly reduced in the TGF-β2 + PHB2 group. After treatment with AGE, cell proliferation and migration in the TGF-β2 + PHB2+AGE group increased, compared to the TGF-β2 + PHB2 group. Compared to the TGF-β2 + Vector group, cell apotosis were significantly promoted in the TGF-β2 + PHB2 group. After treatment with AGE, cell apoptosis in the TGF-β2 + PHB2+AGE group was significantly inhibited, compared to the TGF-β2 + PHB2 group. (Figure 7c).

Figure 7 
                  PHB2 inhibited proliferation, migration, and promoted apoptosis through the AGE–RAGE pathway of ARPE-19 cells. (a) MTT assay detected cell proliferation. (b) Cell migration was detected by wound-healing assay. (c) Apoptosis was detected by flow cytometry. **P < 0.01 compared with the TGF-β2 + vector group. ##
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 7

PHB2 inhibited proliferation, migration, and promoted apoptosis through the AGE–RAGE pathway of ARPE-19 cells. (a) MTT assay detected cell proliferation. (b) Cell migration was detected by wound-healing assay. (c) Apoptosis was detected by flow cytometry. **P < 0.01 compared with the TGF-β2 + vector group. ## P < 0.01 compared with the TGF-β2 + PHB2 group.

3.9 PHB2 inhibits Smad- and non-Smad-dependent pathways by suppressing AGE–RAGE pathways

Compared with those in the control group, we detected apparently higher levels of p-Smad4 and E2F1 in the TGF-β2 group, whereas compared with the TGF-β2 group, there were significant reductions in the expression of p-Smad 4 and E2F1 in the TGF-β2 + PHB2 and TGF-β2 + ALT711 groups. Moreover, the levels of p-Smad4 and E2F1 expression in the TGF-β2 + PHB2 + ALT711 group were found to be markedly lower than those in the TGF-β2 + PHB2 group (Figure 8a). With respect to the non-Smad-dependent pathways, we detected notable increases in the expression of p-PI3K, p-AKT, and p-MEK1/2 in the TGF-β2 group compared with those in the control group, whereas compared with the TGF-β2 group, significantly lower levels of p-PI3K, p-AKT, and p-MEK1/2 expression were detected in the TGF-β2 + PHB2 and TGF-β2 + AL T711 groups. Furthermore, in the TGF-β2 + PHB2 + AL T711 group, the levels of p-PI3K, p-AKT, and p-MEK1/2 expression were found to be significantly lower than those in the TGF-β2 + PHB2 group (Figure 8b).

Figure 8 
                  AGE–RAGE pathway regulated the expression of proteins in Smad-dependent and non-Smad-dependent pathway proteins. (a) Western blotting detected the expressions of Smad4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the control group. ##
                     P < 0.01 compared with the TGF-β2 group. $$
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 8

AGE–RAGE pathway regulated the expression of proteins in Smad-dependent and non-Smad-dependent pathway proteins. (a) Western blotting detected the expressions of Smad4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the control group. ## P < 0.01 compared with the TGF-β2 group. $$ P < 0.01 compared with the TGF-β2 + PHB2 group.

We also established that the levels of p-Smad4 and E2F1 expression in the TGF-β2+PHB2 group were significantly lower than those in the TGF-β2+Vector group. However, we detected an increase in the expression of p-Smad4 and E2F1 in response to AGE treatment in TGF-β2+PHB2+AGE group, compared to the TGF-β2+PHB2 group (Fig. 9A). Additionally, compared with those in the TGF-β2+Vector group, we detected significant reductions in the levels of p-PI3K, p-AKT, and p-MEK1/2 expression in the TGF-β2+PHB2 group. Similar to the aforementioned Smad proteins, AGE treatment was observed to promote the expression of p-PI3K, p-AKT, and p-MEK1/2 in TGF-β2+PHB2+AGE group, compared to the TGF-β2+PHB2 group (Fig. 9B).

Figure 9 
                  PHB2 regulated the expression of proteins in Smad-dependent and non-Smad-dependent pathway proteins through the AGE–RAGE pathway. (a) Western blotting detected the expressions of Smad4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the TGF-β2 + vector group. ##
                     P < 0.01 compared with the TGF-β2 + PHB2 group.
Figure 9

PHB2 regulated the expression of proteins in Smad-dependent and non-Smad-dependent pathway proteins through the AGE–RAGE pathway. (a) Western blotting detected the expressions of Smad4 and E2F1. (b) Western blotting detected the expressions of PI3K, AKT, and MEK1/2. **P < 0.01 compared with the TGF-β2 + vector group. ## P < 0.01 compared with the TGF-β2 + PHB2 group.

4 Discussion

Subretinal fibrosis, a major pathological feature of neovascular age-related macular degeneration, can lead to structural and functional impairment of RPE cells and photoreceptors, thereby causing an irreversible loss of central vision [8]. In this study, we observed fibrosis and a reduction in PHB2 expression in TGF-β2-induced ARPE-19 cells, and on the basis of transcriptome sequencing, we identified the AGE–RAGE pathway as a potential mechanism whereby PHB2 inhibits subretinal fibrosis. Furthermore, overexpression of PHB2 was found to suppress fibrosis in ARPE-19 cells by inhibiting the AGE–RAGE pathway, which was associated with a disruption of ARPE-19 cell proliferation and migration, along with increased levels of apoptosis. In addition, by suppressing the AGE–RAGE pathway, the overexpression of PHB2 was found to contribute to the downregulated expression of both Smad (Smad4 and E2F1) and non-Smad (PI3K, AKT, and MEK1/2)-dependent pathway proteins.

PHB2 has been established to be a key mitochondrial receptor involved in targeted mitochondrial autophagic degradation [19]. It is noteworthy that mitochondrial dysfunction is increasingly being found to be associated with common age-related ophthalmic diseases, including diabetic retinopathy, age-related macular degeneration, and glaucoma [34]. In streptozotocin-treated mouse models and tissues from patients with diabetes, PHB expression has been found to be downregulated and thereby serves as a biomarker for diabetic retinopathy [35]. Additionally, the loss of PHB2 impairs the stability of Optic Atrophy 1 (OPA1), and mutations in OPA1 have been shown to be associated with dominant optic atrophy, characterized by a gradual loss of retinal ganglion cells [36]. In the present study, we observed that TGF-β2 treatment led to a reduction in PHB2 expression and induced fibrosis in ARPE-19 cells, whereas the overexpression of PHB2 was found to inhibit cell proliferation and migration, although also had the effect of enhancing apoptosis. The role of PHB2 in cellular and organ fibrosis has been identified in previous studies. For example, rats with renal interstitial fibrosis were found to be characterized by elevated levels of profibrotic components and reductions in the expression of PHB2, which was inversely correlated with the extent of fibrosis [37]. PHB2 has been shown to ameliorate DOX-induced cardiomyopathy by inhibiting interstitial fibrosis and restoring the mitochondrial complex I function by interacting with NDUFV2 [38]. Collectively, the findings of the present and previous studies provide convincing evidence to indicate that PHB2 plays a pivotal role in both retinal pathologies and organ fibrosis, and by inhibiting fibrosis, the overexpression of PHB2 can contribute to alleviating retinopathy-induced retinal fibrosis.

TGF-β is widely considered to function as a master regulator of tissue fibrosis [39]. In the present study, we found that overexpression of PHB2 inhibited Smad (Smad4/E2F1) and non-Smad (PI3K/AKT/MEK1/2)-dependent pathways in ARPE-19 cells that had been induced by TGF-β1. In TGF-β1-induced cell models, it has previously been established that the abnormal expression of TGF-β1 and phosphorylation of Smad2 and Smad3 are downregulated, thereby tending to indicate that inhibition of the TGF-β/Smad pathway prevents epithelial–mesenchymal transition in fibrosis [40]. In this regard, it has been demonstrated that TGF-β2 promotes subretinal fibrosis by inducing the transformation of pericytes to myofibroblasts via the Smad2/3 and Akt/mTOR pathways [41]. Additionally, specific deletion of Smad4 in hepatocytes has been found to reduce liver inflammation and fibrosis, reverse the suppression of epithelial–mesenchymal transformation, and inhibit hepatocyte proliferation and migration [42]. Non-Smad-dependent pathways have similarly been established to be associated with the development of fibrosis. For example, activation of the PI3K/AKT/ERK signaling pathway has been detected in the retinal tissue of myopic guinea pigs, thereby exacerbating fibrotic lesions and reducing retinal thickness, ultimately resulting in physiological malfunction of the retina [43]. Similarly, activation of the MEK1/2-ERK1/2 signaling pathway has been shown to promote extracellular matrix deposition, oxidative stress damage, and cardiac fibrosis [44]. Studies conducted to date have also established that PHB2 expression is negatively correlated with the degree of renal interstitial fibrosis and levels of TGF-β1 in the tissues of fibrotic rats. Collectively, these findings provide evidence to indicate the pivotal role of PHB2 in the TGF-β-induced fibrotic process [37]. On the basis of our findings in the present study, we conclude that the overexpression of PHB2 contributes to inhibiting Smad- and non-Smad-dependent pathways in TGF-β2-induced ARPE-19 cells, thereby inhibiting fibrosis.

In this study, we identified the AGE–RAGE pathway, which was activated in TGF-β2-induced ARPE-19 cells, as the pathway associated with the fibrosis-related regulatory activity of PHB2, The AGE–RAGE pathway has been established to be a key regulatory pathway in retinal diseases. For example, network pharmacology analysis has revealed that the anti-diabetic retinopathy effect of astragalus in diabetic complications is mainly mediated through the AGE–RAGE signaling pathway [45]. Furthermore, this pathway is considered to be a potentially key target for the treatment of diabetic retinopathy [46]. Moreover, the role of the AGE–RAGE pathway in fibrosis of a range of different organs and tissues has been reported. For example, DEGs in fibrotic breast tissues have been found to be significantly enriched in the AGE–RAGE pathway, thereby indicating that this pathway may play a key role in the development of fibrosis [47]. Consistent with this assumption, oral administration of pomegranate fruit extract has been demonstrated to reduce necrotizing inflammation of the portal vein and suppress fibrosis by inhibiting the expression of AGEs and RAGEs [28]. Similarly, by modulating the AGE–RAGE/HMGB-1 signaling pathway, which affects oxidative stress, inflammation, and fibrosis, artemisinin has been shown to contribute to the amelioration of diabetic cardiomyopathy [48]. Notably, in the present study, we found that by suppressing the AGE–RAGE pathway, the overexpression of.PHB2 in TGF-β2-stimulated ARPE-19 cells inhibited fibrosis, as well as inhibiting cell proliferation and migration and promoting apoptosis. Similarly, by inhibiting the AGE–RAGE pathway, PHB2 also blocked both Smad- and non-Smad-dependent pathways. In this context, research has indicated that the RAGE inhibitor tetrahydroberberine can reverse cardiac aging by enhancing PHB2-mediated mitophagy and prevents peritoneal adhesions by suppressing inflammation [49]. This evidence for the differing roles of PHB2 in different biological contexts highlights the functional complexity of this protein in cellular processes. In the present study, however, we conclude that overexpression of PHB2 inhibits fibrosis of ARPE-19 cells induced by TGF-β2 by suppressing the AGE–RAGE pathway.

However, although our findings in this study provide valuable insights regarding potential biomarkers for subretinal fibrosis, the study does have certain limitations that should be taken into consideration when interpreting the results. Notably, among the primary limitations is the lack of experimental data regarding the inhibition of PHB2. Owing to constraints associated with sample size and experimental duration, we were unable to conduct knockout experiments for PHB2, which would have enabled us to perform a more direct assessment of the role of this protein in subretinal fibrosis. This limitation may accordingly influence the robustness of our conclusions with respect to the specific functions and mechanisms of PHB2 in the context of subretinal fibrosis. We acknowledge this limitation and are committed to addressing this shortcoming in our future research. Despite this limitation, our findings in this study provide important preliminary data that will lay the groundwork for future investigations into the role of PHB2 in subretinal fibrosis.

5 Conclusion

Collectively, our findings in this study indicate that PHB2 would be a promising therapeutic target for the treatment of subretinal fibrosis. Overexpression of PHB2 was found to inhibit subretinal fibrosis by inhibiting the Smad- and non-Smad-dependent pathways in TGF-β2-induced ARPE-19 cells via suppression of the AGE–RAGE pathway. These findings accordingly provide valuable insights into the mechanisms whereby PHB2 alleviates subretinal fibrosis and highlight its potential value as a target for the treatment of subretinal fibrosis.


tel: +86-13380064686

  1. Funding information: Basic Research Plan of Guangzhou Science and Technology Bureau in 2023. No. 2023A03J0907.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and consented to its submission to the journal, reviewed all the results, and approved the final version of the manuscript. Feng Chen: conception, design and analysis of data, performed the data analyses, and wrote the manuscript. Xiaoxiao Cai and Ying Yu: performed the data analyses and reviewed the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Intartaglia D, Giamundo G, Conte I. Autophagy in the retinal pigment epithelium: a new vision and future challenges. FEBS J. 2022;289(22):7199–212.10.1111/febs.16018Search in Google Scholar PubMed PubMed Central

[2] Mudhar HS. A brief review of the histopathology of proliferative vitreoretinopathy (PVR). Eye (Lond). 2020;34(2):246–50.10.1038/s41433-019-0724-4Search in Google Scholar PubMed PubMed Central

[3] Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: Emerging roles in age-related macular degeneration. Int J Mol Sci. 2020;21(12):4271.10.3390/ijms21124271Search in Google Scholar PubMed PubMed Central

[4] Tenbrock L, Wolf J, Boneva S, Schlecht A, Agostini H, Wieghofer P, et al. Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives. Cell Tissue Res. 2022;387(3):361–75.10.1007/s00441-021-03514-8Search in Google Scholar PubMed PubMed Central

[5] Little K, Ma JH, Yang N, Chen M, Xu H. Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration – the potential sources and molecular cues for their recruitment and activation. EBioMedicine. 2018;38:283–91.10.1016/j.ebiom.2018.11.029Search in Google Scholar PubMed PubMed Central

[6] Stylianou A, Gkretsi V, Stylianopoulos T. Transforming growth factor-beta modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion. Biochim Et Biophys Acta Gen Subj. 2018;1862(7):1537–46.10.1016/j.bbagen.2018.02.009Search in Google Scholar PubMed PubMed Central

[7] Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074.10.1038/nrdp.2017.74Search in Google Scholar PubMed

[8] Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–59.10.1016/S0140-6736(18)31550-2Search in Google Scholar PubMed

[9] Zhang W, Han H. Targeting matrix stiffness-induced activation of retinal pigment epithelial cells through the RhoA/YAP pathway ameliorates proliferative vitreoretinopathy. Exp Eye Res. 2021;209:108677.10.1016/j.exer.2021.108677Search in Google Scholar PubMed

[10] Wu D, Kanda A, Liu Y, Kase S, Noda K, Ishida S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition. FASEB J. 2019;33(2):2498–513.10.1096/fj.201801227RSearch in Google Scholar PubMed

[11] Dalla Pozza E, Forciniti S, Palmieri M, Dando I. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development. Semin Cell Dev Biol. 2018;78:62–72.10.1016/j.semcdb.2017.06.027Search in Google Scholar PubMed

[12] Domenico SD, Daniele V. The many-faced program of epithelial–mesenchymal transition: a system biology-based view. Front Oncol. 2017;7:274.10.3389/fonc.2017.00274Search in Google Scholar PubMed PubMed Central

[13] Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol Metab. 2009;20(8):394–401.10.1016/j.tem.2009.04.004Search in Google Scholar PubMed

[14] Signorile A, Sgaramella G, Bellomo F, De Rasmo D. Prohibitins: A critical role in mitochondrial functions and implication in diseases. Cells. 2019;8(1):71.10.3390/cells8010071Search in Google Scholar PubMed PubMed Central

[15] Lachén-Montes M, González-Morales A, Zelaya MV, Pérez-Valderrama E, Ausín K, Ferrer I, et al. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression. Sci Rep. 2017;7(1):9115.10.1038/s41598-017-09481-xSearch in Google Scholar PubMed PubMed Central

[16] Koushyar S, Jiang WG, Dart DA. Unveiling the potential of prohibitin in cancer. Cancer Lett. 2015;369(2):316–22.10.1016/j.canlet.2015.09.012Search in Google Scholar PubMed

[17] Dutta D, Ali N, Banerjee E, Singh R, Naskar A, Paidi RK, et al. Low levels of prohibitin in substantia nigra makes dopaminergic neurons vulnerable in Parkinson’s disease. Mol Neurobiol. 2018;55(1):804–21.10.1007/s12035-016-0328-ySearch in Google Scholar PubMed

[18] Ising C, Koehler S, Brähler S, Merkwirth C, Höhne M, Baris OR, et al. Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol Med. 2015;7(3):275–87.10.15252/emmm.201404916Search in Google Scholar PubMed PubMed Central

[19] Wei Y, Chiang WC, Sumpter R, Mishra P, Levine B. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell. 2017;168(1–2):224–38.e10.10.1016/j.cell.2016.11.042Search in Google Scholar PubMed PubMed Central

[20] Wang X, Song M, Li X, Su C, Yang Y, Wang K, et al. CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease. Am J Physiol Cell Physiol. 2023;325(2):C538–49.10.1152/ajpcell.00144.2023Search in Google Scholar PubMed PubMed Central

[21] Ye J, Li J, Xia R, Zhou M, Yu L. Prohibitin protects proximal tubule epithelial cells against oxidative injury through mitochondrial pathways. Free Radic Res. 2015;49(11):1393–403.10.3109/10715762.2015.1075654Search in Google Scholar PubMed

[22] Yang T, Yang Q, Lai Q, Zhao J, Nie L, Liu S, et al. AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction. Biomed Pharmacother. 2023;165:115195.10.1016/j.biopha.2023.115195Search in Google Scholar PubMed

[23] Zhang Y, Wang Z, Lan D, Zhao J, Wang L, Shao X, et al. MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2. Pharmacol Res. 2022;177:106124.10.1016/j.phrs.2022.106124Search in Google Scholar PubMed

[24] Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11(8):1312.10.3390/cells11081312Search in Google Scholar PubMed PubMed Central

[25] Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542.10.3390/biom12040542Search in Google Scholar PubMed PubMed Central

[26] Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, et al. Activation and modulation of the AGEs-RAGE Axis: Implications for inflammatory pathologies and therapeutic interventions-A review. Pharmacol Res. 2024;206:107282.10.1016/j.phrs.2024.107282Search in Google Scholar PubMed

[27] Martín-Carro B, Martín-Vírgala J, Fernández-Villabrille S, Fernández-Fernández A, Pérez-Basterrechea M, Navarro-González JF, et al. Role of Klotho and AGE/RAGE-Wnt/β-catenin signalling pathway on the development of cardiac and renal fibrosis in diabetes. Int J Mol Sci. 2023;24(6):5241.10.3390/ijms24065241Search in Google Scholar PubMed PubMed Central

[28] Abouelezz HM, Shehatou GSG, Shebl AM, Salem HA. A standardized pomegranate fruit extract ameliorates thioacetamide-induced liver fibrosis in rats via AGE-RAGE-ROS signaling. Heliyon. 2023;9(3):e14256.10.1016/j.heliyon.2023.e14256Search in Google Scholar PubMed PubMed Central

[29] Shao D, Liu X, Wu J, Zhang A, Bai Y, Zhao P, et al. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology. Phytomedicine. 2022;102:154177.10.1016/j.phymed.2022.154177Search in Google Scholar PubMed

[30] Mengstie MA, Chekol Abebe E, Behaile Teklemariam A, Tilahun Mulu A, Agidew MM, Teshome Azezew M, et al. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front Mol Biosci. 2022;9:1002710.10.3389/fmolb.2022.1002710Search in Google Scholar PubMed PubMed Central

[31] Xu J, Chen LJ, Yu J, Wang HJ, Zhang F, Liu Q, et al. Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy. Cell Physiol Biochem. 2018;48(2):705–17.10.1159/000491897Search in Google Scholar PubMed

[32] Oshitari T. Advanced glycation end-products and diabetic neuropathy of the retina. Int J Mol Sci. 2023;24(3):2927.10.3390/ijms24032927Search in Google Scholar PubMed PubMed Central

[33] Chiang CK, Wang CC, Lu TF, Huang KH, Sheu ML, Liu SH, et al. Involvement of endoplasmic reticulum stress, autophagy, and apoptosis in advanced glycation end products-induced glomerular mesangial cell injury. Sci Rep. 2016;6:34167.10.1038/srep34167Search in Google Scholar PubMed PubMed Central

[34] Kisilevsky E, Freund P, Margolin E. Mitochondrial disorders and the eye. Surv Ophthalmol. 65(3):294–311.10.1016/j.survophthal.2019.11.001Search in Google Scholar PubMed

[35] Patrick AT, He W, Madu J, Sripathi SR, Choi S, Lee K, et al. Mechanistic dissection of diabetic retinopathy using the protein-metabolite interactome. J Diabetes Metab Disord. 2020;19(2):829–48.10.1007/s40200-020-00570-9Search in Google Scholar PubMed PubMed Central

[36] Merkwirth C, Martinelli P, Korwitz A, Morbin M, Brönneke HS, Jordan SD, et al. Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet. 2012;8(11):e1003021.10.1371/journal.pgen.1003021Search in Google Scholar PubMed PubMed Central

[37] Zhou TB, Qin YH, Lei FY, Huang WF, Drummen GP. Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis. Mol Biol Rep. 2014;41(5):3033–43.10.1007/s11033-014-3162-1Search in Google Scholar PubMed

[38] Yang M, Abudureyimu M, Wang X, Zhou Y, Zhang Y, Ren J. PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function. Redox Biol. 2023;65:102812.10.1016/j.redox.2023.102812Search in Google Scholar PubMed PubMed Central

[39] Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–38.10.1038/nrneph.2016.48Search in Google Scholar PubMed

[40] Ding D, Shen X, Yu L, Zheng Y, Liu Y, Wang W, et al. Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis. Phytother Res. 2023;37(7):2787–99.10.1002/ptr.7774Search in Google Scholar PubMed

[41] Zhao Z, Zhang Y, Zhang C, Zhang J, Luo X, Qiu Q, et al. TGF-β promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways. Exp Mol Med. 2022;54(5):673–84.10.1038/s12276-022-00778-0Search in Google Scholar PubMed PubMed Central

[42] Wei M, Yan X, Xin X, Chen H, Hou L, Zhang J. Hepatocyte-specific Smad4 deficiency alleviates liver fibrosis via the p38/p65 pathway. Int J Mol Sci. 2022;23(19):11696.10.3390/ijms231911696Search in Google Scholar PubMed PubMed Central

[43] Bao B, Liu J, Li T, Yang Z, Wang G, Xin J, et al. Elevated retinal fibrosis in experimental myopia is involved in the activation of the PI3K/AKT/ERK signaling pathway. Arch Biochem Biophys. 2023;743:109663.10.1016/j.abb.2023.109663Search in Google Scholar PubMed

[44] Wu X, Li M, Chen SQ, Li S, Guo F. Pin1 facilitates isoproterenol‑induced cardiac fibrosis and collagen deposition by promoting oxidative stress and activating the MEK1/2‑ERK1/2 signal transduction pathway in rats. Int J Mol Med. 2018;41(3):1573–83.10.3892/ijmm.2017.3354Search in Google Scholar PubMed PubMed Central

[45] Lin X, Bao M, Zhang X, Qirula S, Jiao C, Zhang D, et al. Study on the bioactive ingredients and mechanism of Huangqi against diabetic retinopathy based on network pharmacology and experimental verification. J Chin Med Assoc. 2024;87(8):10–97.10.1097/JCMA.0000000000001113Search in Google Scholar PubMed

[46] Wu X, Mu L, Dong Z, Wu J, Zhang S, Su J, et al. Hu-Zhang Qing-Mai Formulation anti-oxidative stress alleviates diabetic retinopathy: Network pharmacology analysis and in vitro experiment. Med (Baltim). 2023;102(36):e35034.10.1097/MD.0000000000035034Search in Google Scholar PubMed PubMed Central

[47] Syed MA, Bhat B, Wali A, Saleem A, Ahmad Dar L, Gugjoo MB, et al. Epithelial to mesenchymal transition in mammary gland tissue fibrosis and insights into drug therapeutics. PeerJ. 2023;11:e15207.10.7717/peerj.15207Search in Google Scholar PubMed PubMed Central

[48] Farrag EAE, Hammad MO, Safwat SM, Hamed S, Hellal D. Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE/HMGB-1 signaling pathway. Sci Rep. 2023;13(1):11043.10.1038/s41598-023-37678-wSearch in Google Scholar PubMed PubMed Central

[49] Xu HH, Hao SX, Sun HY, Dong XX, Lin Y, Lou H, et al. THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation. Acta Pharmacol Sin. 2024;45(10):2107–18.10.1038/s41401-024-01307-7Search in Google Scholar PubMed PubMed Central

Received: 2024-05-28
Revised: 2024-09-03
Accepted: 2024-09-23
Published Online: 2024-11-04

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0985/html
Scroll to top button